COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

Andrea Matucci, Marco Caminati, Emanuele Vivarelli, Andrea Vianello, Claudio Micheletto, Francesco Menzella, Ernesto Crisafulli, Giovanni Passalacqua, Diego Bagnasco, Carlo Lombardi, Paola Parronchi, Mariaangiola A. Crivellaro, Fulvia Chieco-Bianchi, Maria Rita Marchi, Gabriella Guarnieri, Lorenzo Cosmi, Oliviero Rossi, Fabio Almerigogna, Gianenrico Senna, Alessandra Vultaggio

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalAllergy: European Journal of Allergy and Clinical Immunology
Publication statusE-pub ahead of print - Jul 27 2020
Externally publishedYes


  • asthma
  • biologics
  • infections
  • virus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this